JUSTIN MAIO: Open Payments
NPI 1043647381 · HONOLULU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,398 in 150 payments from 20 companies in 2025. Trend: 2023 $3,062 · 2024 $2,389 · 2025 $3,398
Food & beverage: $3,281Education: $116
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $531 |
| Lilly USA, LLC | 13 | $369 |
| GENZYME CORPORATION | 9 | $335 |
| LEO Pharma Inc. | 16 | $293 |
| UCB, Inc. | 10 | $284 |
| Regeneron Healthcare Solutions, Inc. | 9 | $273 |
| Galderma Laboratories, L.P. | 15 | $244 |
| Organon LLC | 9 | $188 |
| Arcutis Biotherapeutics, Inc. | 15 | $175 |
| Amgen Inc. | 8 | $169 |
Products named: DUPIXENT, SKYRIZI, TALTZ, Bimzelx, ADBRY, NEMLUVIO, Zoryve, OTEZLA.
Industry payments across HI — which companies pay providers there.
